The Swiss Medtech industry, accustomed to success, has been in a state of tension for some time. On the one hand, the approximately 1500 Swiss Medtech companies are in regulatory limbo due to the loss of "privileged market access to the EU," and on the other hand, technological advances, and particularly Artificial Intelligence, are revolutionizing the high-margin Medtech market at an unprecedented pace. The upheaval is reflected in an increasingly differentiated and [...]
Healthcare Stocks: How the hype around AI and weight-loss injections is shaping the stock market
